News
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire - Genmab Publishes 2021 Annual Report
02/16/2022 / 17:00 - GlobeNewswire - BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
02/16/2022 / 11:30 - GlobeNewswire - BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide an Update on Sustainable Vaccine Manufacturing in Africa
02/15/2022 / 15:40 - GlobeNewswire - Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA
02/01/2022 / 22:27 - GlobeNewswire - Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
01/25/2022 / 12:45 - GlobeNewswire
Real-time